Famotidine and Norfloxacin drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among 31 people who take Famotidine and Norfloxacin. Common interactions include diarrhoea among females, and bankruptcy among males.
The phase IV clinical study analyzes what interactions people who take Famotidine and Norfloxacin have. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
31 people who take Famotidine and Norfloxacin together, and have interactions are studied.
What is Famotidine?
Famotidine has active ingredients of famotidine. It is used in gastroesophageal reflux disease. Currently, eHealthMe is studying from 75,949 Famotidine users.
What is Norfloxacin?
Norfloxacin has active ingredients of norfloxacin. It is used in urinary tract infection. Currently, eHealthMe is studying from 2,342 Norfloxacin users.
Number of Famotidine and Norfloxacin reports submitted per year:

Common Famotidine and Norfloxacin drug interactions by gender *:
female:
- Diarrhoea
- Abdominal pain
- Anasarca
- Blood beta-d-glucan increased
- Blood bilirubin increased
- Convulsions
- Dementia
- Depressed level of consciousness
- Diabetic nephropathy
- Hypoglycaemia
male:
- Bankruptcy
- Drug dependence
- Pulmonary tuberculosis
- Staphylococcal sepsis
- Vomiting
- Abdominal pain
- Acute graft versus host disease in skin
- Acute myeloid leukaemia
- Cardio-respiratory arrest
- Constipation
Common Famotidine and Norfloxacin drug interactions by age *:
0-1:
n/a
2-9:
- Alanine aminotransferase increased
- Aspartate aminotransferase increased
- Bacterial infection
- Cytokine storm
- Hypertension
10-19:
- Staphylococcal sepsis
- Acute graft versus host disease in skin
- Acute myeloid leukaemia
- Epstein-barr virus associated lymphoproliferative disorder
- Metastases to lung
- Respiratory failure
- Post transplant lymphoproliferative disorder
20-29:
- Pulmonary tuberculosis
- Upper respiratory tract infection
- Dysuria
- Eye irritation
- Hepatomegaly
- Micturition urgency
- Pollakiuria
- Urine abnormality
30-39:
n/a
40-49:
- Abdominal pain
- Anasarca
- Blood beta-d-glucan increased
- Blood bilirubin increased
- Diarrhoea
- Lip pain
- Loose stools
- Pharyngolaryngeal pain
- Pneumonia
- Protein total decreased
50-59:
- Duodenal polyp
- Gastric polyps
- Bilirubinuria
- Fatigue
- Hepatitis
- Hepatomegaly
- Jaundice
- Urine discolouration
60+:
- Dementia
- Diabetic nephropathy
- Blister
- C-reactive protein increased
- Diabetic coma
- Dizziness (excl vertigo)
- Dysphagia
- Epidermal necrolysis
- Face oedema
- Feeding disorder
Common conditions people have *:
- Gastrointestinal Disorder (functional problems of gastrointestinal tract): 3 people, 9.68%
- Diarrhea: 3 people, 9.68%
- Brain Oedema (excess accumulation of fluid in the intracellular or extracellular spaces of the brain): 3 people, 9.68%
- Bone Marrow Conditioning Regimen: 3 people, 9.68%
- Allergies: 3 people, 9.68%
- Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 3 people, 9.68%
- Pneumonia: 2 people, 6.45%
- Pain: 2 people, 6.45%
- Lung Cancer - Non-Small Cell (lung cancer): 2 people, 6.45%
- Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 2 people, 6.45%
* Approximation only. Some reports may have incomplete information.
Do you take Famotidine and Norfloxacin?
Personalize this study to your gender and ageHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related studies
Drug side effects by duration, gender and age:
- Famotidine side effects (75,949 reports)
- Norfloxacin side effects (2,342 reports)
Common Famotidine drug interactions:
- Famotidine and Aspirin: 11,654 reports
- Famotidine and Prednisone: 7,722 reports
- Famotidine and Amlodipine: 7,720 reports
- Famotidine and Omeprazole: 7,719 reports
- Famotidine and Furosemide: 7,538 reports
- Famotidine and Gabapentin: 7,325 reports
- Famotidine and Lisinopril: 6,992 reports
- Famotidine and Vitamin d: 6,478 reports
- Famotidine and Ondansetron: 6,349 reports
- Famotidine and Pantoprazole: 6,120 reports
Browse interactions between Famotidine and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon Norfloxacin drug interactions:
- Norfloxacin and Prednisone: 425 reports
- Norfloxacin and Methotrexate: 420 reports
- Norfloxacin and Humira: 333 reports
- Norfloxacin and Metronidazole: 311 reports
- Norfloxacin and Sulfasalazine: 310 reports
- Norfloxacin and Demerol: 304 reports
- Norfloxacin and Arava: 303 reports
- Norfloxacin and Arthrotec: 299 reports
- Norfloxacin and Celecoxib: 286 reports
- Norfloxacin and Leflunomide: 282 reports
Browse interactions between Norfloxacin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on famotidine and norfloxacin (the active ingredients of Famotidine and Norfloxacin, respectively), and Famotidine and Norfloxacin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Famotidine and Norfloxacin.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Cogentin and Alcohol Withdrawal Syndrome - 6 seconds ago
- Moxifloxacin Hydrochloride and Risedronate Sodium drug interaction - 7 seconds ago
- Clarithromycin and Navane drug interaction - 8 seconds ago
- Herceptin and Chest X-Ray Abnormal - 9 seconds ago
- Cresemba and Ceftriaxone drug interaction - 28 seconds ago
- Calcium Citrate and Caffeine drug interaction - 28 seconds ago
- Salonpas and Calcitriol drug interaction - 32 seconds ago
- Sprycel and Levothroid drug interaction - 32 seconds ago
- Mucinex and Fosamax drug interaction - 40 seconds ago
- Letairis and Metaglip drug interaction - 53 seconds ago